The correlation of CTG repeat length with material and social deprivation in myotonic dystrophy

Clinical Genetics

Volumn 71, Issue 1, 2007, Pages 59-66

  Laberge, L ^a,b,c   Veillette, S ^a,c   Mathieu, J ^c,d   Auclair, J ^a   Perron, Michael ^a,c  

^a Groupe ÉCOBES   (Canada)

^b UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Neuromuscular Clinic   (Canada)

Author keywords

CTG repeats; Genotype; Myotonic dystrophy; Phenotype; Social support; Socioeconomic deprivation

Indexed keywords

CYSTEINE; GENOMIC DNA; GLYCINE; THREONINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMPLOYMENT STATUS; FAMILY RELATION; FEMALE; GENETIC CORRELATION; GENOTYPE PHENOTYPE CORRELATION; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SOCIAL STATUS; SOCIAL SUPPORT; SOCIOECONOMICS; TRINUCLEOTIDE REPEAT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; QUEBEC; QUESTIONNAIRES; SEX FACTORS; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 33845513938     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00732.x     Document Type: Article

References (39)

1. Harper PS. Myotonic dystrophy. Philadelphia: W.B. Saunders, 2001.
2. Harley HG, Brook JD, Rundle SA et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992: 355: 545-546.
3. Hunter A, Tsilfidis C, Mettler G et al. The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet 1992: 29: 774-779.
4. Mathieu J, De Braekeleer M, Prevost C. Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada). Neurology 1990: 40: 839-842.
5. Adie WJ, Greenfield JG. Dystrophia myotonica. Brain 1923: 45: 73-127.
6. Thomasen E. Myotonia. Denmark: Aarhuus Universitetsforlaget, 1948.
7. Caughey JE, Myrianthopoulos NC. Dystrophia myotonica and related disorders. Springfield, III: Charles C Thomas, 1963.
8. Perron M, Veillette S, Mathieu J. Myotonic dystrophy: I. Socioeconomic and residential characteristics of the patients. Can J Neurol Sci 1989: 16: 109-113.
9. Veillette S, Perron M, Mathieu J et al. Sociocultural factors influencing the spread of myotonic dystrophy in the Saguenay-Lac-Saint-Jean region of the province of Quebec (Canada). In: Bittles AH, Roberts DF, eds. Minority populations. London: The Macmillan Press Ltd, 1990: 83-101.
10. Wilcox DE, Bower M. Sharing information, knowledge, and experience to build a team to help manage myotonic dystrophy. In: Harper PS, van Engelen BGM, Eymard B, Wilcox DE, eds. Myotonic dystrophy: Present management, future therapy. Oxford: Oxford University Press, 2004: 193-207.
11. Wilkinson R, Marmot M. Social determinants of health: The solid facts. Geneva: World Health Organization, 1998.
12. Mathieu J, Boivin H, Meunier D et al. Assessment of a disease-specific impairment rating scale in myotonic dystrophy. Neurology 2001: 56: 336-340.
13. Statistics Canada. Community highlights for Région du Saguenay-Lac-Saint-Jean. Statistics Canada Census, Ottawa, 2001.
14. Vézina A. Le travail et le réseau de support comme facteurs d'adaptation chez les veuves d'âge moyen. Québec: École de psychologie, UniversitéLaval, 1988.
15. St-Onge M, Lavoie F. The experience of caregiving among mothers of adults suffering from psychotic disorders: Factors associated with their psychological distress. Am J Community Psychol 1997: 25: 73-94.
16. Procidano ME, Heller K. Measures of perceived social support from friends and from family: Three validation studies. Am J Community Psychol 1983: 11: 1-24.
17. Furling D, Lemieux D, Taneja K, Puymirat J. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul Disord 2001: 11: 728-735.
18. Létourneau E, AndréD, Bernier M et al. Familles et santé. In: Enquête sociale et de Santé1998 Québec: Institut de la statistique du Québec, 2000: 502-503.
19. Jenkins R. Disability and social stratification. Br J Sociol 1990: 42: 557-580.
20. Novelli G, Gennarelli M, Menegazzo E et al. (CTG)n triplet mutation and phenotype manifestations in myotonic dystrophy patients. Biochem Med Metab Biol 1993: 50: 85-92.
21. Mastrogiacomo I, Pagani E, Novelli G et al. Male hypogonadism in myotonic dystrophy is related to (CTG)n triplet mutation. J Endocrinol Invest 1994: 17: 381-383.
22. Jaspert A, Fahsold R, Grehl H, Claus D. Myotonic dystrophy: Correlation of clinical symptoms with the size of the CTG trinucleotide repeat. J Neurol 1995: 242: 99-104.
23. Melacini P, Villanova C, Menegazzo E et al. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 1995: 25: 239-245.
24. Gharehbaghi-Schnell EB, Finsterer J, Korschineck I et al. Genotype-phenotype correlation in myotonic dystrophy. Clin Genet 1998: 53: 20-26.
25. Marchini C, Lonigro R, Verriello L et al. Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet 2000: 57: 74-82.
26. Finsterer J, Gharehbaghi-Schnell E, Stollberger C et al. Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet 2001: 59: 350-355.
27. Logigian EL, Moxley RT III, Blood CL et al. Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1. Neurology 2004: 62: 1081-1089.
28. Arsenault ME, Prevost C, Lescault A et al. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions. Neurology 2006: 66: 1248-1250.
29. Winblad S, Lindberg C, Hansen S. Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1). Behav Brain Funct 2006: 2: 16.
30. Fowler WM Jr, Abresch RT, Koch TR et al. Employment profiles in neuromuscular diseases. Am J Phys Med Rehabil 1997: 76: 26-37.
31. Kalkman JS, Schillings ML, van der Werf SP et al. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry 2005: 76: 1406-1409.
32. Andries F, Wevers CW, Wintzen AR et al. Vocational perspectives and neuromuscular disorders. Int J Rehabil Res 1997: 20: 255-273.
33. Wilson WJ. The truly disadvantaged. Chicago: University of Chicago Press, 1987.
34. Wacquant LJD, Wilson WJ. The cost of racial and class exclusion in the inner city. Ann Am Acad Polit Soc Sci 1989: 501: 8-25.
35. Kawachi I, Kennedy BP. Health and social cohesion: Why care about income inequality? BMJ 1997: 314: 1037-1040.
36. House JS, Landis KR, Umberson D. Social relationships and health. Science 1988: 241: 540-545.
37. Gulbrandsen P, Fugelli P, Sandvik L, Hjortdahl P. Influence of social problems on management in general practice: Multipractice questionnaire survey. BMJ 1998: 317: 28-32.
38. Gulbrandsen P, Hjortdahl P, Fugelli P. General practitioners' knowledge of their patients' psychosocial problems: Multipractice questionnaire survey. BMJ 1997: 314: 1014-1018.
39. van Haastregt JC, de Witte LP, Terpstra SJ et al. Membership of a patients' association and well-being. A study into the relationship between membership of a patients' association, fellow-patient contact, information received, and psychosocial well-being of people with a neuromuscular disease. Patient Educ Couns 1994: 24: 135-148.